Article
HIFs, angiogenesis, and metabolism: elusive enemies in breast cancer
1 Sept 2020
Abstract excerpt
Hypoxia-inducible factors (HIFs) and the HIF-dependent cancer hallmarks angiogenesis and metabolic rewiring are well-established drivers of breast cancer aggressiveness, therapy resistance, and poor prognosis. Targeting of HIF and its downstream targets in angiogenesis and metabolism has been unsuccessful so far in the breast cancer clinical setting, with major unresolved challenges residing in target selection,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
